Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 444 followers
Latest posts
Last updated 2 days ago
Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Status: Opinion
Human medicines European public assessment report (EPAR): Denosumab BBL, denosumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Denosumab BBL, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Enwylma, denosumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Enwylma, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion
Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Alyftrek, deutivacaftor / tezacaftor / vanzacaftor, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Alyftrek, deutivacaftor / tezacaftor /...
Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Status: Opinion
Human medicines European public assessment report (EPAR): Junod, denosumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Junod, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Status: Opinion
Human medicines European public assessment report (EPAR): Tepezza, teprotumumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Tepezza, teprotumumab, Status: Opinion